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Background: Although cavernous hemangioma is one of the most frequently encountered benign hepatic
neoplasms, hepatic sclerosed hemangioma is very rare. We report a case of hepatic sclerosed hemangioma that
was difficult to distinguish from an intrahepatic cholangiocarcinoma by imaging studies.
Case presentation: A 76-year-old male patient with right hypochondralgia was referred to our hospital.
Abdominal ultrasonography revealed a heterogeneously hyperechoic tumor that was 59 mm in diameter in
segment 7 of the liver. Dynamic computed tomography showed a low-density tumor with delayed ring enhancement.
Gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid-enhanced magnetic resonance imaging (EOB-MRI)
demonstrated a low-signal intensity mass with ring enhancement on T1-weighted images. The mass had several
high-signal intensity lesions on T2-weighted images. EOB-MRI revealed a hypointense nodule on the hepatobiliary
phase. From these imaging studies, the tumor was diagnosed as intrahepatic cholangiocarcinoma, and we performed
laparoscopy-assisted posterior sectionectomy of the liver with lymph node dissection in the hepatoduodenal ligament.
Histopathological examination revealed a hepatic sclerosed hemangioma with hyalinized tissue and collagen fibers.
Conclusion: Hepatic sclerosed hemangioma is difficult to diagnose preoperatively because of its various imaging
findings. We report a case of hepatic sclerosed hemangioma and review the literatures, especially those concerning
imaging findings.
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The preoperative diagnosis of hepatic sclerosed heman-
gioma is very difficult, even with recent developments in
radiological modalities, because it is an extremely rare
benign disorder and its radiological features resemble
those of hepatic malignancies such as cholangiocarci-
noma and metastatic liver cancer [1,2]. We report a case
of a hepatic sclerosed hemangioma, that had been pre-
operatively misdiagnosed as an intrahepatic cholangio-
carcinoma and been resected, and review the relevant
literature, especially summarizing the imaging findings
of hepatic sclerosed hemaigioma.* Correspondence: oshita-akihiko@umin.ac.jp
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A 76-year-old male patient had consulted a doctor for
upper abdominal pain 16 months before being referred
to us and had been followed up. Because plain computed
tomography (CT) revealed a space-occupying lesion in
the liver, he was referred to our hospital. A laboratory
workup on admission showed that total bilirubin, aspar-
tate aminotransferase, alanine aminotransferase, alkaline
phosphatase, gamma-glutamyl transpeptidase, albumin,
and creatinine were all within normal ranges. Tumor
markers including alpha-fetoprotein, protein induced by
vitamin K absence or antagonist-II, carcinoembryonic
antigen, and carbohydrate antigens 19–9 were also
within the normal limits (Table 1).
Abdominal ultrasonography (US) revealed a well-defined,
heterogeneously hyperechoic mass that was 59 mm in
diameter in segment 7 of the liver (Figure 1). Plain CT
revealed a low-density 60-mm sized mass with an ir-
regular margin. Dynamic CT revealed early ring enhance-
ment in the peripheral part on the arterial phase andtral. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Table 1 Review of imaging features for Hepatic Sclerosed Hamangioma
Case Year Author Age Gender Location Size (mm) US Plain CT Dynamic CT MRI (T1/T2) PET-CT Preoperative diagnosis Final diagnosis
1 1995 Ishii 81 F S3 25 Low Low Ring enhanced Low/Low ― Not determined sclerosed hemangioma
2 1995 Haratake 64 F S8 26 ― Low Ring enhanced ― ― Metastatic liver cancer sclerosed hemangioma
3 1996 Kobayashi 49 F S7 22 High Low Ring enhanced Low/High ― Not determined sclerosed hemangioma
4 1998 Ukai 66 F S6 10 Low Low Ring enhanced Low/High ― Hepatocellular carcinoma sclerosed hemangioma
5 2000 Yamashita 67 F S4 50 Low Low Ring enhanced High/High ― Metastatic liver cancer sclerosing hemangioma
6 2001 Okada 77 M S8 23 High Low Not enhanced ― ― Metastatic liver cancer sclerosed hemangioma
7 2001 Aibe 67 F S4 40 ― Low Not enhanced High/High ― Metastatic liver cancer sclerosed hemangioma
8 2003 Hayakawa 70 F S2 30 Low Low Ring enhanced Low/Iso-High ― Not determined sclerosed hemangioma
9 2005 Morikawa 66 M S8 50 Iso Low Ring enhanced Low/High Not accumulated Not determined sclerosed hemangioma
10 2005 Lee 65 F S6 53 ― ― Ring enhanced Low/High ― Hepatocellular carcinoma sclerosing hemangioma
11 2005 Okamoto 50 F S3 30 Low Low Ring enhanced ― ― sclerosed hemangioma sclerosed hemangioma
12 2006 Hamatsu 59 M S8 25 High Low Ring enhanced ― ― Metastatic liver cancer sclerosed hemangioma
13 2006 Hayashi 82 F S2/3 55 High Low Not enhanced Low/High ― Gastric submucosal tumor sclerosed hemangioma
14 2006 Iida 77 F S2 39 High Low Ring enhanced Low/Low-High Not accumulated Not determined sclerosing hemaigioma
15 2007 Sawai 67 F Right robe 145 Low Low Ring enhanced Low/High ― Not determined sclerosed hemangioma
16 2008 Kaji 65 F S5 25 Low Low Ring enhanced Low/Iso-High ― Cholangiocarcinoma sclerosed hemangioma
17 2008 Tsumaki 70 F S8 47 Low Low Ring enhanced Low/High ― Liver sclerosed hemangioma sclerosed hemangioma
18 2008 Mori 77 F S6 100 High Low Not enhanced Low/High ― Cholangiocarcinoma sclerosed hemangioma
19 2010 Yoshida 75 F S5/6 37 High Low Ring enhanced Low/High Not accumulated Cholangiocarcinoma sclerosing hemaigioma
20 2010 Usui 57 F S2 17 Low Low Ring enhanced Low/High ― Metastatic liver cancer sclerosed hemangioma
21 2010 Jin 52 M S6/7 38 ― ― Ring enhanced Low/High ― Hepatocellular carcinoma sclerosed hemangioma
22 2010 Hida 75 F S5/6 30 High ― Ring enhanced Low/High ― Metastatic liver cancer sclerosed hemangioma
23 2011 Miyaki 60’s F S3 30 Low Low ― Low/High ― Liver sclerosed hemangioma sclerosed hemangioma
24 2011 Kitami 72 F S3 55 Low Low Ring enhanced Low/High ― Cholangiocarcinoma sclerosed hemangioma
25 2011 Tanaka 71 M S6 15 High Low Ring enhanced ― ― Hepatocellular carcinoma sclerosed hemangioma
26 2011 Mikami 74 F S2 22 Low Low Ring enhanced Low/High Not accumulated Not determined sclerosed hemangioma
27 2011 Shin 50 M Right robe 100 Iso-Low Low Ring enhanced Low/High Not accumulated Liver sclerosing hemangioma sclerosing hemangioma
28 2012 Wakasugi 61 F S2, S5 25,5 Low ― Ring enhanced Low/High ― Metastatic liver cancer sclerosed hemangioma
29 2012 Yamada 75 M S8 11 ― Low Ring enhanced Low/High Not accumulated Metastatic liver cancer sclerosed hemangioma
30 2013 Song 63 F S2/3 91 ― Low Ring enhanced ― ― Not determined sclerosing hemangioma
31 2013 Shimada 63 M S8 10 ― Low Ring enhanced Low/High ― Atypical hemangioma sclerosed hemangioma













Figure 1 Abdominal ultrasonography (US). US showed a
heterogeneously hyperechoic mass in segment 7 of the liver.
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(Figure 2). Gadolinium-ethoxybenzyl-diethylenetriamine
pentaacetic acid-enhanced magnetic resonance imaging
(EOB-MRI) showed that the tumor had low-signal inten-
sity on T1-weighted images and that the mass had some
high-signal intensity foci in the tumor on T2-weighted im-
ages. EOB-MRI showed no uptake in the corresponding
area on the hepatobiliary phase and ring enhancement in
the peripheral part on the arterial phase and the portal
phase (Figure 3).
Laparoscopy-assisted posterior sectionectomy and chole-
cystectomy including lymph node dissection in the hepato-
duodenal ligament were performed for a preoperative
diagnosis of intrahepatic cholangiocarcinoma. The resectedFigure 2 Abdominal computed tomography (CT). (a) plain, (b) arterial pha
low-density mass. Dynamic CT showed the ring enhancement in the peripspecimen revealed a white solid mass, sized 61 × 46 mm.
The cut surface of the tumor was elastic, soft, and homoge-
neous with the smooth margin including some faint red
spots up to 10 mm in size (Figure 4a).
Histopathological examination showed that the tumor
was composed of fibrous connective tissue highlighted with
collagen fibers and various sizes of cavernous hemangioma
tissue with some hyaline degeneration secondary to
thrombus, necrosis, or cicatrization, resulting in a hepatic
sclerosed hemangioma (Figure 4b).
The postoperative course was uneventful. The patient
was discharged on postoperative day 6.Discussion
Hepatic sclerosed hemangioma, first reported by Ishii in
1995 [1], is a rare disease, detected and reported in only
2 out of 1000 cases on autopsy [3]. We found only 9
cases in PubMed by manual searching for the terms
“hepatic, sclerosed, hemangioma” and “hepatic, scleros-
ing, hemangioma” from January 1983 to January 2015.
Additionally, we found 22 cases in ICHUSHI, a biblio-
graphic database established in 1903 and being updated
by the Japan Medical Abstracts Society, contains biblio-
graphic citations and abstracts from more than 2500
biomedical journals and other serial publications pub-
lished in Japanese. The 32 cases, including our case, are
summarized in Table 1 [1,4-33].
Hepatic sclerosed hemangioma is caused by degenera-
tive changes such as thrombus formation, necrosis, and
scar formation of liver cavernous hemangioma, but the
mechanism for degenerative changes in the hepatic cavern-
ous hemangioma has not been well clarified at present [34].se, (c) portal venous phase, and (d) delayed phase. Plain CT showed a
heral part on the arterial phase (arrow).
Figure 3 Magnetic resonance imaging (MRI). (a) T1-weighted
image, (b) T2-weighted image, and (c) ethoxybenzyl (EOB)-MRI
on the hepatobiliary phase. The tumor had low-signal intensity
on T1-weighted and some high-signal intensity nodules in the
tumor on T2-weighted images. EOB-MRI showed no uptake in
the corresponding area on the hepatobiliary phase.
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rized the imaging findings of 10 hepatic sclerosed
hemangioma lesions and found the characteristic fea-
tures to include a geographic pattern, capsular retrac-
tion, decrease in size over time, loss of previously seen
regions of enhancement [2]. And additional characteris-
tic, features included the presence of transient hepatic
attenuation difference, ring enhancement, and nodular
regions of intense enhancement as seen in typical
hemangioma. In our series reviewed the average size of
the hepatic sclerosed hemangiomas was 42.3 mm, ranging
from 10 to 145 mm. Abdominal US showed a hyperechoic
mass in 11 cases and a hypoechoic tumor in 13 cases. Plain
CT was likely to show a low-density mass, and dynamicFigure 4 Resected specimen. (a) Surface of slice. The cut surface of
the tumor reveals a white solid mass (61 × 46 mm in size) that was
elastic, soft, and homogeneous with a smooth margin including
some faint red spots, sized 1 cm. (b) Hematoxylin and eosin staining
(magnification, ×100). The tumor was composed of fibrous
connective tissue highlighted with collagen fiber and various sizes
of cavernous hemangioma tissue with some hyaline degeneration
secondary to thrombus, necrosis, or cicatrization.CT showed ring enhancement, resembling metastatic liver
cancer or intrahepatic cholangiocarcinoma, in 27 of 31 re-
ported cases. MRI showed a low-intensity signal in 24 of
26 reported cases on T1-weighted images and a high-
intensity signal in 22 of 26 reported cases on T2-
weighted images. The radiological features revealed by
dynamic CT and MRI resembled those of hepatic malig-
nancies, leading to preoperative misdiagnosis. Whereas,
[18F]-fluorodeoxyglucose positron emission tomography
(FDG-PET), performed in just 6 cases, showed no accu-
mulation of [18F]-FDG (Table 1). FDG-PET could be
helpful in preoperative diagnosis to distinguish benign
sclerosed hemangioma from malignant tumors such as
intrahepatic cholangiocarcinomas or metastatic liver
cancers. We may have had to perform FDG-PET
preoperatively.
Surgical resection for hepatic sclerosed hemangioma
is controversial. Most of the tumors reported were
resected due to a preoperative misdiagnosis of malig-
nancy (Table 1). To make a definite diagnosis of such
hepatic tumors, percutaneous needle biopsy is not ac-
ceptable because of the possibility of dissemination of
the cancer cells if the tumor is malignant. Therefore
we would suggest that hepatic resections are chosen
for the management of hepatic sclerosed hemangioma
at present.
Makhlouf and Ishak compared the findings of sclerosed
hemangioma and sclerosing cavernous hemangioma.
According to their theory, recent hemorrhages and he-
mosiderin deposits rich in mast cells are present in the
sclerosing hemangioma. While, fibrosis, increased elastic
fibers, and dystrophic or psammomatous calcifications
with a decreased number of mast cells can be observed in
the sclerosed hemangioma [35]. Our case showed a fi-
brous connective tissue highlighted with collagen fibers
and various sizes of cavernous hemangioma tissue with
some hyaline degeneration. These findings are consistent
with features of hepatic sclerosed hemangioma, resulting
in the final diagnosis.
Conclusion
We report a case with a hepatic sclerosed hemangioma.
Although it is a rare disease, it is important to distin-
guish hepatic sclerosed hemangioma from hepatic ma-
lignancies. However, it is extremely difficult to diagnose
precisely from imaging studies. If the possibility of a
malignant tumor cannot be ruled out, hepatic resection
might be selected for diagnostic therapy.
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